EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
ALX Oncology Holdings Inc. (ALXO) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-17.97M |
|
-- |
|
-- |
|
$18.03M |
|
$-18.03M |
|
$0.06M |
|
$-17.97M |
|
$-17.97M |
|
$-17.97M |
|
$-17.97M |
|
$-17.97M |
|
$-17.97M |
|
$-18.03M |
|
$-18.22M |
|
135.64M |
|
135.64M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$143.46M |
|
$0.17M |
|
$17.36M |
|
$160.82M |
|
$14.78M |
|
$9.71M |
|
$9.86M |
|
$24.63M |
|
$136.19M |
|
$136.19M |
|
$136.19M |
|
138.22M |
|
| Cash Flow Statement Financials | |
$-34.70M |
|
$-98.51M |
|
$139.73M |
|
$16.44M |
|
$22.95M |
|
$6.51M |
|
$5.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.71 |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-34.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.20% |
|
-13.20% |
|
-11.17% |
|
-12.32% |
|
$0.99 |
|
$-0.26 |
|
$-0.26 |
|